{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:47:04Z","timestamp":1789588024724,"version":"build-2803163510"},"reference-count":78,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Project for Practical Application of Rare and Intractable Diseases, Japan Agency for Medical Research and Development (AMED)","award":["JP23ek0109665h0001"],"award-info":[{"award-number":["JP23ek0109665h0001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Sarcopenia, a serious consequence of chronic kidney disease (CKD), is driven by elevated myostatin (MSTN), a key inhibitor of muscle growth. This study explored the potential of an MSTN-specific antisense oligonucleotide (ASO) in reversing CKD-induced muscle wasting in a mouse model. Thirty-two male C57BL\/6J mice were randomly assigned to a non-CKD group (n = 8, regular diet) and a CKD group (n = 24, adenine diet). CKD was induced using a 0.2% adenine-supplemented diet for 4 weeks. Following this, the mice were sub-grouped into CKD (saline, n = 8), CKD + Low-Dose ASO (25 mg\/kg ASO, n = 8), and CKD + High-Dose ASO (50 mg\/kg ASO, n = 8). ASO was administered via subcutaneous injections for 8 weeks. Muscle mass, treadmill performance, grip strength, and muscle fiber morphology were assessed alongside qPCR and Western blot analysis for MSTN, atrogin-1, and MuRF-1 expression. ASO therapy significantly enhanced muscle mass and function and enlarged muscle fibers while effectively downregulating muscle degradation markers. These improvements occurred without compromising renal function, as confirmed by BUN, creatinine, kidney weight, and histological analysis. This study is the first to demonstrate the efficacy of ASO therapy in mitigating CKD-induced sarcopenia, offering a promising targeted gene therapy with significant clinical implications for improving nutritional status and physical performance in CKD.<\/jats:p>","DOI":"10.3390\/ijms26073098","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T04:11:40Z","timestamp":1743135100000},"page":"3098","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibiting Myostatin Expression by the Antisense Oligonucleotides Improves Muscle Wasting in a Chronic Kidney Disease Mouse Model"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3833-1552","authenticated-orcid":false,"given":"Arju","family":"Akhter","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo 693-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1221-7787","authenticated-orcid":false,"given":"Abdullah","family":"Md. Sheikh","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo 693-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9833-4356","authenticated-orcid":false,"given":"Jun","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo 693-8501, Japan"},{"name":"The Center for Integrated Kidney Research and Advance (IKRA), Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo 693-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo 693-8501, Japan"},{"name":"The Center for Integrated Kidney Research and Advance (IKRA), Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo 693-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9280-8044","authenticated-orcid":false,"given":"Atsushi","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo 693-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6747-7194","authenticated-orcid":false,"given":"Masafumi","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Graduate School of Science, Technology and Innovation, Kobe University, Kobe 657-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9210-2949","authenticated-orcid":false,"given":"Shozo","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo 693-8501, Japan"},{"name":"The Center for Integrated Kidney Research and Advance (IKRA), Faculty of Medicine, Shimane University, 89-1 Enya-Cho, Izumo 693-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-021-00898-1","article-title":"Sarcopenia in Chronic Kidney Disease: A Scoping Review of Prevalence, Risk Factors, Association with Outcomes, and Treatment","volume":"110","author":"Chatzipetrou","year":"2022","journal-title":"Calcif. Tissue Int."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Massini, G., Caldiroli, L., Molinari, P., Carminati, F.M.I., Castellano, G., and Vettoretti, S. (2023). Nutritional Strategies to Prevent Muscle Loss and Sarcopenia in Chronic Kidney Disease: What Do We Currently Know?. Nutrients, 15.","DOI":"10.3390\/nu15143107"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Moreno-Gonzalez, R., Corbella, X., Mattace-Raso, F., Tap, L., Sieber, C., Freiberger, E., Kostka, T., Guligowska, A., Melzer, I., and Melzer, Y. (2020). Prevalence of Sarcopenia in Community-Dwelling Older Adults Using the Updated EWGSOP2 Definition According to Kidney Function and Albuminuria: The Screening for CKD among Older People across Europe (SCOPE) Study. BMC Geriatr., 20.","DOI":"10.1186\/s12877-020-01700-x"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Liu, T., Wu, Y., Cao, X., Yang, K., Tong, Y., Zhang, F., Wang, C., Cui, R., Ren, J., and Li, Q. (2024). Association between Sarcopenia and New-Onset Chronic Kidney Disease among Middle-Aged and Elder Adults: Findings from the China Health and Retirement Longitudinal Study. BMC Geriatr., 24.","DOI":"10.1186\/s12877-024-04691-1"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/ndt\/gfad100","article-title":"Association between CKD-MBD and Mortality in Older Patients with Advanced CKD\u2014Results from the EQUAL Study","volume":"38","author":"Magagnoli","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Martins, P., Marques, E.A., Leal, D.V., Ferreira, A., Wilund, K.R., and Viana, J.L. (2021). Association between Physical Activity and Mortality in End-Stage Kidney Disease: A Systematic Review of Observational Studies. BMC Nephrol., 22.","DOI":"10.1186\/s12882-021-02407-w"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1007\/s12325-023-02608-9","article-title":"Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme","volume":"40","author":"Jha","year":"2023","journal-title":"Adv. Ther."},{"key":"ref_8","first-page":"1","article-title":"Sarcopenia, the Economic Challenges in Healthcare and Individual Struggles Arise","volume":"11","author":"Wang","year":"2024","journal-title":"Open Access Libr. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40266-023-01093-7","article-title":"The Current Landscape of Pharmacotherapies for Sarcopenia","volume":"41","author":"Bahat","year":"2024","journal-title":"Drugs Aging"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/sdi.12832","article-title":"Cachexia\/Protein Energy Wasting Syndrome in CKD: Causation and Treatment","volume":"32","author":"Oliveira","year":"2019","journal-title":"Semin. Dial."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/jcsm.12791","article-title":"Resistance Exercise and Nutritional Interventions for Augmenting Sarcopenia Outcomes in Chronic Kidney Disease: A Narrative Review","volume":"12","author":"Noor","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wang, K., Liu, Q., Tang, M., Qi, G., Qiu, C., Huang, Y., Yu, W., Wang, W., Sun, H., and Ni, X. (2023). Chronic Kidney Disease-Induced Muscle Atrophy: Molecular Mechanisms and Promising Therapies. Biochem. Pharmacol., 208.","DOI":"10.1016\/j.bcp.2022.115407"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tsai, C.-C., Wang, P.-C., Hsiung, T., Fan, Y.-H., Wu, J.-T., Kan, W.-C., and Shiao, C.-C. (2025). Sarcopenia in Chronic Kidney Disease: A Narrative Review from Pathophysiology to Therapeutic Approaches. Biomedicines, 13.","DOI":"10.20944\/preprints202501.0340.v1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1248\/bpb.b19-00513","article-title":"Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions","volume":"42","author":"Watanabe","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"F1128","DOI":"10.1152\/ajprenal.00600.2016","article-title":"Chronic Kidney Disease Induces Autophagy Leading to Dysfunction of Mitochondria in Skeletal Muscle","volume":"312","author":"Su","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/ndt\/gfaa129","article-title":"Myostatin and Muscle Atrophy during Chronic Kidney Disease","volume":"36","author":"Bataille","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Baig, M.H., Ahmad, K., Moon, J.S., Park, S.-Y., Ho Lim, J., Chun, H.J., Qadri, A.F., Hwang, Y.C., Jan, A.T., and Ahmad, S.S. (2022). Myostatin and Its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.876078"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"684965","DOI":"10.1155\/2015\/684965","article-title":"Myostatin Activates the Ubiquitin-Proteasome and Autophagy-Lysosome Systems Contributing to Muscle Wasting in Chronic Kidney Disease","volume":"2015","author":"Wang","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal Muscle Atrophy and the E3 Ubiquitin Ligases MuRF1 and MAFbx\/Atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am. J. Physiol-Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Degens, H., Patel, K., and Matsakas, A. (2025). Myostatin Knockout Mice Have Larger Muscle Fibers with Normal Function and Morphology. Muscle Nerve, ahead of print.","DOI":"10.1002\/mus.28389"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1152\/physiol.2024.39.S1.1888","article-title":"Deletion of Myostatin Significantly and Preferentially Improves Muscle Function in a Sex-Dependent Manner in Both an Obese and Aging Mouse Model","volume":"39","author":"Butler","year":"2024","journal-title":"Physiology"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Cs\u00fcrh\u00e9s, T., Szab\u00f3, F., Holl\u00f3, G., Mik\u00f3, E., T\u00f6r\u00f6k, M., and Bene, S. (2023). Relationship between Some Myostatin Variants and Meat Production Related Calving, Weaning and Muscularity Traits in Charolais Cattle. Animals, 13.","DOI":"10.20944\/preprints202305.0317.v1"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"RP86827","DOI":"10.7554\/eLife.86827.3","article-title":"A MSTNDel73C Mutation with FGF5 Knockout Sheep by CRISPR\/Cas9 Promotes Skeletal Muscle Myofiber Hyperplasia","volume":"12","author":"Chen","year":"2024","journal-title":"eLife"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Grochowska, E., Borys, B., and Mroczkowski, S. (2019). Effects of Intronic SNPs in the Myostatin Gene on Growth and Carcass Traits in Colored Polish Merino Sheep. Genes, 11.","DOI":"10.3390\/genes11010002"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ceccobelli, S., Perini, F., Trombetta, M.F., Tavoletti, S., Lasagna, E., and Pasquini, M. (2022). Effect of Myostatin Gene Mutation on Slaughtering Performance and Meat Quality in Marchigiana Bulls. Animals, 12.","DOI":"10.3390\/ani12040518"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13395-016-0085-7","article-title":"Dystrophin-Deficient Dogs with Reduced Myostatin Have Unequal Muscle Growth and Greater Joint Contractures","volume":"6","author":"Kornegay","year":"2016","journal-title":"Skelet. Muscle"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbrc.2023.06.053","article-title":"Dual Single Guide RNAs-Mediating Deletion of Mature Myostatin Peptide Results in Concomitant Muscle Fibre Hyperplasia and Adipocyte Hypotrophy in Pigs","volume":"673","author":"Hua","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/jcmm.16238","article-title":"Formononetin Ameliorates Muscle Atrophy by Regulating Myostatin-Mediated PI3K\/Akt\/FoxO3a Pathway and Satellite Cell Function in Chronic Kidney Disease","volume":"25","author":"Liu","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jcsm.12162","article-title":"Suppression of Muscle Wasting by the Plant-Derived Compound Ursolic Acid in a Model of Chronic Kidney Disease","volume":"8","author":"Yu","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Heitman, K., Alexander, M.S., and Faul, C. (2024). Skeletal Muscle Injury in Chronic Kidney Disease-From Histologic Changes to Molecular Mechanisms and to Novel Therapies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25105117"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Eilers, W., Cleasby, M., and Foster, K. (2021). Development of Antisense-Mediated Myostatin Knockdown for the Treatment of Insulin Resistance. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-81222-7"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jcsm.12542","article-title":"Myostatin Inhibition in Combination with Antisense Oligonucleotide Therapy Improves Outcomes in Spinal Muscular Atrophy","volume":"11","author":"Zhou","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/nat.2020.0845","article-title":"The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy","volume":"30","author":"Corey","year":"2020","journal-title":"Nucleic Acid. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kemaladewi, D.U., Hoogaars, W.M., van Heiningen, S.H., Terlouw, S., de Gorter, D.J., den Dunnen, J.T., van Ommen, G.J.B., Aartsma-Rus, A., ten Dijke, P., and \u2019t Hoen, P.A. (2011). Dual Exon Skipping in Myostatin and Dystrophin for Duchenne Muscular Dystrophy. BMC Med. Genomics., 4.","DOI":"10.1186\/1755-8794-4-36"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/kidneydial2010004","article-title":"Antisense Oligonucleotide: A Potential Therapeutic Intervention for Chronic Kidney Disease","volume":"2","author":"Li","year":"2022","journal-title":"Kidney Dial."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Maeta, K., Farea, M., Nishio, H., and Matsuo, M. (2022). An Antisense Oligonucleotide against a Splicing Enhancer Sequence within Exon 1 of the MSTN Gene Inhibits Pre-mRNA Maturation to Act as a Novel Myostatin Inhibitor. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095016"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e13696","DOI":"10.1002\/jcsm.13696","article-title":"Multiomics Analysis Reveals Therapeutic Targets for Chronic Kidney Disease with Sarcopenia","volume":"16","author":"Wang","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Heitman, K., Bollenbecker, S., Bradley, J., Czaya, B., Fajol, A., Thomas, S.M., Li, Q., Komarova, S., Krick, S., and Rowe, G.C. (2024). Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Mice. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179308"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"F106","DOI":"10.1152\/ajprenal.00117.2021","article-title":"Skeletal Myopathy in CKD: A Comparison of Adenine-Induced Nephropathy and 5\/6 Nephrectomy Models in Mice","volume":"321","author":"Kim","year":"2021","journal-title":"Am. J. PhysiolRen. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/hmg\/ddx431","article-title":"Myostatin Inhibition Using mRK35 Produces Skeletal Muscle Growth and Tubular Aggregate Formation in Wild Type and TgACTA1D286G Nemaline Myopathy Mice","volume":"27","author":"Tinklenberg","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13395-017-0141-y","article-title":"A Mouse Anti-Myostatin Antibody Increases Muscle Mass and Improves Muscle Strength and Contractility in the Mdx Mouse Model of Duchenne Muscular Dystrophy and Its Humanized Equivalent, Domagrozumab (PF-06252616), Increases Muscle Volume in Cynomolgus Monkeys","volume":"7","author":"Johnson","year":"2017","journal-title":"Skeletal Muscle"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Okamoto, K., Kasukawa, Y., Nozaka, K., Tsuchie, H., Kudo, D., Kinoshita, H., Ono, Y., Igarashi, S., Kasama, F., and Harata, S. (2024). Changes in Skeletal Muscle Atrophy over Time in a Rat Model of Adenine-Induced Chronic Kidney Disease. Appl. Sci., 14.","DOI":"10.20944\/preprints202408.1421.v1"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Lindqvist, J., and Granzier, H. (2023). Pharmacological Inhibition of Myostatin in a Mouse Model of Typical Nemaline Myopathy Increases Muscle Size and Force. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242015124"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e10833","DOI":"10.1002\/jbm4.10833","article-title":"Pharmacologic Inhibition of Myostatin with a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin-Deficient Diabetic Mice","volume":"7","author":"Bunn","year":"2023","journal-title":"JBMR Plus."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ki.2012.84","article-title":"Transcription Factor FoxO1, the Dominant Mediator of Muscle Wasting in Chronic Kidney Disease, Is Inhibited by microRNA-486","volume":"82","author":"Xu","year":"2012","journal-title":"Kidney Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13395-015-0060-8","article-title":"Myostatin Blockade with a Fully Human Monoclonal Antibody Induces Muscle Hypertrophy and Reverses Muscle Atrophy in Young and Aged Mice","volume":"5","author":"Latres","year":"2015","journal-title":"Skeletal Muscle"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13395-019-0197-y","article-title":"A GDF11\/Myostatin Inhibitor, GDF11 Propeptide-Fc, Increases Skeletal Muscle Mass and Improves Muscle Strength in Dystrophic Mdx Mice","volume":"9","author":"Jin","year":"2019","journal-title":"Skeletal Muscle"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Avin, K.G., Chen, N.X., Organ, J.M., Zarse, C., O\u2019Neill, K., Conway, R.G., Konrad, R.J., Bacallao, R.L., Allen, M.R., and Moe, S.M. (2016). Skeletal Muscle Regeneration and Oxidative Stress Are Altered in Chronic Kidney Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159411"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1089\/dna.2020.5423","article-title":"Skeletal Muscle Anti-Atrophic Effects of Leucine Involve Myostatin Inhibition","volume":"39","author":"Cruz","year":"2020","journal-title":"DNA Cell Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.kint.2016.07.029","article-title":"The Pathway to Muscle Fibrosis Depends on Myostatin Stimulating the Differentiation of Fibro\/Adipogenic Progenitor Cells in Chronic Kidney Disease","volume":"91","author":"Dong","year":"2017","journal-title":"Kidney Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.afos.2021.11.001","article-title":"Analysis of Bone in Adenine-Induced Chronic Kidney Disease Model Rats","volume":"7","author":"Saito","year":"2021","journal-title":"Osteoporos. Sarcopenia."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Rahman, A., Yamazaki, D., Sufiun, A., Kitada, K., Hitomi, H., Nakano, D., and Nishiyama, A. (2018). A Novel Approach to Adenine-Induced Chronic Kidney Disease Associated Anemia in Rodents. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192531"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Li, Q., Wu, J., Huang, J., Hu, R., You, H., Liu, L., Wang, D., and Wei, L. (2022). Paeoniflorin Ameliorates Skeletal Muscle Atrophy in Chronic Kidney Disease via AMPK\/SIRT1\/PGC-1\u03b1-Mediated Oxidative Stress and Mitochondrial Dysfunction. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.859723"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Atay, J.C.L., Elsborg, S.H., Palmfeldt, J., Nejsum, L.N., and N\u00f8rregaard, R. (2024). Recovery of Water Homeostasis in Adenine-Induced Kidney Disease Is Mediated by Increased AQP2 Membrane Targeting. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063447"},{"key":"ref_56","first-page":"3957","article-title":"Inhibiting Myostatin Reverses Muscle Fibrosis through Apoptosis","volume":"125","author":"Li","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e29093","DOI":"10.1016\/j.heliyon.2024.e29093","article-title":"Shenshuai Yingyang Jiaonang Ameliorates Chronic Kidney Disease-Associated Muscle Atrophy in Rats by Inhibiting Ferroptosis Mediated by the HIF-1\u03b1\/SLC7A11 Pathway","volume":"10","author":"Ju","year":"2024","journal-title":"Heliyon"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of Activin A and Myostatin in Human Cancer Cachexia","volume":"100","author":"Loumaye","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1111\/cas.15491","article-title":"Combination Therapy with Anamorelin and a Myostatin Inhibitor Is Advantageous for Cancer Cachexia in a Mouse Model","volume":"113","author":"Hanada","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e2033457","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults with Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw. Open."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"E163","DOI":"10.1152\/ajpendo.00185.2019","article-title":"Local Myostatin Inhibition Improves Skeletal Muscle Glucose Uptake in Insulin-Resistant High-Fat Diet-Fed Mice","volume":"319","author":"Eilers","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/hum.2010.057","article-title":"Inhibition of Atrogin-1\/MAFbx Expression by Adenovirus-Delivered Small Hairpin RNAs Attenuates Muscle Atrophy in Fasting Mice","volume":"22","author":"Cong","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1113\/jphysiol.2011.212845","article-title":"Muscle Sparing in Muscle RING Finger 1 Null Mice: Response to Synthetic Glucocorticoids","volume":"589","author":"Baehr","year":"2011","journal-title":"J. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00223-024-01283-4","article-title":"Irisin Ameliorates Muscle Atrophy by Inhibiting the Upregulation of the Ubiquitin\u2013Proteasome System in Chronic Kidney Disease","volume":"115","author":"Wang","year":"2024","journal-title":"Calcif. Tissue Int."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Chen, M.-M., Zhao, Y.-P., Zhao, Y., Deng, S.-L., and Yu, K. (2021). Regulation of Myostatin on the Growth and Development of Skeletal Muscle. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.785712"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s11357-023-00956-6","article-title":"Skeletal Muscle Myostatin mRNA Expression Is Upregulated in Aged Human Adults with Excess Adiposity but Is Not Associated with Insulin Resistance and Ageing","volume":"46","author":"Wilhelmsen","year":"2023","journal-title":"GeroScience"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/en.2015-1546","article-title":"Myostatin Attenuation In Vivo Reduces Adiposity, but Activates Adipogenesis","volume":"157","author":"Li","year":"2016","journal-title":"Endocrinology"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Verzola, D., Milanesi, S., Viazzi, F., Ansaldo, F., Saio, M., Garibaldi, S., Carta, A., Costigliolo, F., Salvidio, G., and Barisione, C. (2020). Enhanced Myostatin Expression and Signalling Promote Tubulo-interstitial Inflammation in Diabetic Nephropathy. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-62875-2"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.kint.2018.10.010","article-title":"Emerging Role of Myostatin and Its Inhibition in the Setting of Chronic Kidney Disease","volume":"95","author":"Verzola","year":"2019","journal-title":"Kidney Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"101120","DOI":"10.1016\/j.molmet.2020.101120","article-title":"Beige Fat Is Dispensable for the Metabolic Benefits Associated with Myostatin Deletion","volume":"43","author":"Marchildon","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.arcmed.2019.12.020","article-title":"Indoxyl Sulfate Contributes to Uremic Sarcopenia by Inducing Apoptosis in Myoblasts","volume":"51","author":"Rodrigues","year":"2020","journal-title":"Arch. Med. Res."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Nishi, H., Takemura, K., Higashihara, T., and Inagi, R. (2020). Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach. Nutrients, 12.","DOI":"10.3390\/nu12061814"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/ndt\/gfac136","article-title":"Mechanisms of Myostatin and Activin A Accumulation in Chronic Kidney Disease","volume":"37","author":"Bataille","year":"2022","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.jrn.2022.01.011","article-title":"The Relationship Between Myostatin, Inflammatory Markers, and Sarcopenia in Patients With Chronic Kidney Disease","volume":"32","author":"Yasar","year":"2022","journal-title":"J. Ren. Nutr."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Lee, T., Awano, H., Yagi, M., Matsumoto, M., Watanabe, N., Goda, R., Koizumi, M., Takeshima, Y., and Matsuo, M. (2017). 2\u2032-O-Methyl RNA\/Ethylene-Bridged Nucleic Acid Chimera Antisense Oligonucleotides to Induce Dystrophin Exon 45 Skipping. Genes, 8.","DOI":"10.3390\/genes8020067"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/cimb43030090","article-title":"Renadirsen, a Novel 2\u2032OMeRNA\/ENA\u00ae Chimera Antisense Oligonucleotide, Induces Robust Exon 45 Skipping for Dystrophin In Vivo","volume":"43","author":"Ito","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.exger.2013.06.004","article-title":"A Myostatin Inhibitor (Propeptide-Fc) Increases Muscle Mass and Muscle Fiber Size in Aged Mice but Does Not Increase Bone Density or Bone Strength","volume":"48","author":"Arounleut","year":"2013","journal-title":"Exp. Gerontol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.expneurol.2018.10.001","article-title":"A Mesenchymal Stem Cell Line (B10) Increases Angiogenesis in a Rat MCAO Model","volume":"311","author":"Sheikh","year":"2019","journal-title":"Exp. Neurol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/7\/3098\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:03:38Z","timestamp":1760029418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/7\/3098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":78,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["ijms26073098"],"URL":"https:\/\/doi.org\/10.3390\/ijms26073098","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}